Variant report

Variant	rs2285681
Chromosome Location	chr7:19158766-19158767
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr7:19158378-19159418	H1-neurons	neurons:	n/a	n/a
2	POLR2A	chr7:19158763-19158996	SK-N-SH	brain:	n/a	n/a
3	E2F6	chr7:19158748-19158883	K562	blood:	n/a	n/a
4	USF1	chr7:19158640-19159060	SK-N-SH	brain:	n/a	n/a
5	GATA2	chr7:19157152-19160135	SH-SY5Y	brain:	n/a	n/a
6	CTCF	chr7:19158691-19158823	Fibrobl	skin:	n/a	n/a
7	MAX	chr7:19158555-19159088	H1-hESC	embryonic stem cell:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
8	MXI1	chr7:19143470-19162161	SK-N-SH	brain:	n/a	chr7:19158827-19158836 chr7:19158829-19158838 chr7:19158827-19158836
9	USF1	chr7:19158554-19158956	SK-N-SH_RA	brain:	n/a	n/a
10	POLR2A	chr7:19158616-19159674	H1-neurons	neurons:	n/a	n/a
11	MAX	chr7:19156834-19159384	SK-N-SH	brain:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
12	USF2	chr7:19158648-19159001	H1-hESC	embryonic stem cell:	n/a	n/a
13	USF1	chr7:19158673-19159040	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr7:19158640-19158790	NHDF-neo	bronchial:	n/a	n/a
15	MYC	chr7:19158669-19158977	H1-hESC	embryonic stem cell:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
16	CTCF	chr7:19158640-19158790	SK-N-SH_RA	brain:	n/a	n/a
17	E2F6	chr7:19158458-19159138	H1-hESC	embryonic stem cell:	n/a	chr7:19158719-19158731
18	USF1	chr7:19158539-19159111	H1-hESC	embryonic stem cell:	n/a	n/a
19	GTF2F1	chr7:19158758-19158951	H1-hESC	embryonic stem cell:	n/a	n/a
20	MAX	chr7:19158516-19159067	H1-hESC	embryonic stem cell:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
21	POLR2A	chr7:19156719-19160247	SK-N-SH	brain:	n/a	n/a
22	SIN3AK20	chr7:19158521-19159082	SK-N-SH	brain:	n/a	n/a
23	CTBP2	chr7:19155933-19159128	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr7:19158680-19158830	HCPEpiC	choroid plexus:	n/a	n/a
25	USF1	chr7:19158669-19159020	SK-N-SH_RA	brain:	n/a	n/a
26	RAD21	chr7:19157780-19162195	SK-N-SH	brain:	n/a	chr7:19158102-19158121 chr7:19158107-19158119
27	MAX	chr7:19158688-19158944	K562	blood:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
28	MAX	chr7:19158507-19159170	H1-hESC	embryonic stem cell:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
29	EP300	chr7:19158578-19158918	SK-N-SH_RA	brain:	n/a	n/a
30	RAD21	chr7:19158549-19158965	SK-N-SH_RA	brain:	n/a	n/a
31	CTCF	chr7:19158660-19158810	AG04449	skin:	n/a	n/a
32	EP300	chr7:19155676-19158995	SK-N-SH	brain:	n/a	chr7:19157558-19157574 chr7:19155896-19155905 chr7:19157535-19157544
33	REST	chr7:19158548-19159073	SK-N-SH	brain:	n/a	n/a
34	MXI1	chr7:19158650-19159063	H1-hESC	embryonic stem cell:	n/a	chr7:19158827-19158836 chr7:19158829-19158838 chr7:19158827-19158836
35	CTCF	chr7:19158740-19158890	SAEC	small airway:	n/a	n/a
36	E2F6	chr7:19158553-19159075	H1-hESC	embryonic stem cell:	n/a	chr7:19158719-19158731
37	MAX	chr7:19158698-19158873	K562	blood:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
38	MAX	chr7:19158354-19159240	SK-N-SH	brain:	n/a	chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158827-19158838 chr7:19158826-19158839 chr7:19158828-19158838 chr7:19158827-19158838 chr7:19158828-19158838 chr7:19158828-19158837 chr7:19158827-19158837 chr7:19158826-19158839 chr7:19158827-19158837
39	CTCF	chr7:19158760-19158910	SK-N-SH_RA	brain:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:19158721-19158771	AG04450	lung:	fetal
2	chr7:19158721-19158771	U87	brain:	n/a
3	chr7:19158747-19158797	CMK	blood:	n/a
4	chr7:19158721-19158771	BE2_C	brain:	n/a
5	chr7:19158721-19158771	GM12891	blood:	n/a
6	chr7:19158747-19158797	SK-N-SH_RA	brain:	n/a
7	chr7:19158721-19158771	LNCaP	prostate:	n/a
8	chr7:19158721-19158771	GM06990	blood:	n/a
9	chr7:19158721-19158771	NH-A	brain:	n/a
10	chr7:19158721-19158771	HCPEpiC	choroid plexus:	n/a
11	chr7:19158747-19158797	GM12892	blood:	n/a
12	chr7:19158747-19158797	AoSMC	blood vessel:	n/a
13	chr7:19158747-19158797	HMEC	breast:	n/a
14	chr7:19158747-19158797	MCF-7	breast:	n/a
15	chr7:19158721-19158771	HMEC	breast:	n/a
16	chr7:19158747-19158797	NH-A	brain:	n/a
17	chr7:19158747-19158797	U87	brain:	n/a
18	chr7:19158747-19158797	SAEC	small airway:	n/a
19	chr7:19158747-19158797	HEEpiC	esophagus:	n/a
20	chr7:19158721-19158771	HAEpiC	amniotic membrane:	n/a
21	chr7:19158747-19158797	AG04449	skin:	fetal
22	chr7:19158747-19158797	HL-60	blood:	n/a
23	chr7:19158721-19158771	A549	lung:	n/a
24	chr7:19158747-19158797	IMR90	lung:	fetal
25	chr7:19158747-19158797	MCF10A-Er-Src	breast:	n/a
26	chr7:19158747-19158797	T-47D	breast:	n/a
27	chr7:19158747-19158797	BE2_C	brain:	n/a
28	chr7:19158747-19158797	NB4	blood:	n/a
29	chr7:19158747-19158797	NHBE	bronchial:	n/a
30	chr7:19158747-19158797	PANC-1	pancreas:	n/a
31	chr7:19158747-19158797	GM12878	blood:	n/a
32	chr7:19158721-19158771	AG09309	skin:	n/a
33	chr7:19158747-19158797	ovcar-3	ovarian:	n/a
34	chr7:19158721-19158771	AG04449	skin:	fetal
35	chr7:19158721-19158771	PANC-1	pancreas:	n/a
36	chr7:19158721-19158771	NHDF-neo	bronchial:	n/a
37	chr7:19158747-19158797	Hepatocyte	liver:	n/a
38	chr7:19158721-19158771	SK-N-MC	brain:	n/a
39	chr7:19158721-19158771	T-47D	breast:	n/a
40	chr7:19158721-19158771	IMR90	lung:	fetal
41	chr7:19158721-19158771	AG10803	skin:	n/a
42	chr7:19158747-19158797	NHDF-neo	bronchial:	n/a
43	chr7:19158721-19158771	Hepatocyte	liver:	n/a
44	chr7:19158721-19158771	Hela-S3	cervix:	n/a
45	chr7:19158721-19158771	ProgFib	skin:	n/a
46	chr7:19158747-19158797	HRE	kidney:	n/a
47	chr7:19158747-19158797	ECC-1	luminal epithelium:	n/a
48	chr7:19158721-19158771	HNPCEpiC	eye:	n/a
49	chr7:19158747-19158797	NT2-D1	testis:	n/a
50	chr7:19158747-19158797	HepG2	liver:	n/a

Variant related genes	Relation type
ENSG00000236536	TF binding region
TWIST1	TF binding region
TWIST1	CpG island
ENSG00000236536	CpG island

Extended variants
information (count: 31 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs10235442	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs10254337	0.80[JPT][hapmap]
rs10275272	1.00[CEU][hapmap];0.85[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2189000	1.00[CEU][hapmap];0.84[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs3801990	0.83[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs3801991	0.83[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs4721745	0.91[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:24 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531020	chr7:18971153-19261019	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
2	nsv532096	chr7:19094324-19361216	Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
3	nsv532097	chr7:19105767-19302951	Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Strong transcription Weak transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
4	nsv538767	chr7:19150355-19163170	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
5	nsv1028132	chr7:19150355-19172107	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
6	nsv538768	chr7:19150355-19172107	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
7	nsv538769	chr7:19150920-19160604	Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	4 gene(s)	inside rSNPs	diseases
8	nsv538770	chr7:19151576-19159136	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Genic enhancers Strong transcription	TF binding region CpG island lncRNA	4 gene(s)	inside rSNPs	n/a
9	nsv538771	chr7:19151576-19162140	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	n/a
10	nsv538772	chr7:19152061-19159275	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription	TF binding region CpG island lncRNA	4 gene(s)	inside rSNPs	n/a
11	nsv538774	chr7:19152455-19162140	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
12	nsv538775	chr7:19152934-19162079	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
13	nsv1023268	chr7:19152934-19172246	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
14	nsv538776	chr7:19152934-19172246	Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
15	nsv538778	chr7:19153407-19159075	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	3 gene(s)	inside rSNPs	n/a
16	nsv538779	chr7:19153407-19159275	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers	TF binding region CpG island lncRNA	3 gene(s)	inside rSNPs	n/a
17	nsv538780	chr7:19153407-19163309	Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
18	nsv538781	chr7:19153408-19159276	Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers	TF binding region CpG island lncRNA	3 gene(s)	inside rSNPs	n/a
19	nsv538782	chr7:19153408-19163310	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
20	nsv1034825	chr7:19153408-19172247	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
21	nsv538783	chr7:19153408-19172247	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
22	nsv538785	chr7:19153607-19163170	Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	n/a
23	nsv538786	chr7:19154379-19159075	Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers	TF binding region CpG island lncRNA	2 gene(s)	inside rSNPs	n/a
24	nsv538788	chr7:19154807-19160743	Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region CpG island lncRNA	2 gene(s)	inside rSNPs	n/a

No data

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:19151800-19158800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr7:19154000-19159000	Active TSS	HSMM	muscle
3	chr7:19155200-19159800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
4	chr7:19155800-19159200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
5	chr7:19156000-19158800	Bivalent Enhancer	Fetal Brain Male	brain
6	chr7:19156400-19158800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
7	chr7:19157000-19158800	Enhancers	Pancreas	Pancrea
8	chr7:19157400-19158800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
9	chr7:19157400-19158800	Bivalent Enhancer	HUVEC	blood vessel
10	chr7:19157600-19158800	Bivalent Enhancer	Spleen	Spleen
11	chr7:19157600-19159000	Bivalent Enhancer	Brain Germinal Matrix	brain
12	chr7:19157600-19159000	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
13	chr7:19157600-19159200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
14	chr7:19157600-19159600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr7:19157800-19159000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
16	chr7:19157800-19159000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
17	chr7:19157800-19159200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr7:19157800-19159200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr7:19158000-19158800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
20	chr7:19158000-19158800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
21	chr7:19158000-19158800	Bivalent Enhancer	Brain Hippocampus Middle	brain
22	chr7:19158000-19158800	Bivalent Enhancer	HMEC	breast
23	chr7:19158000-19159000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr7:19158000-19159200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr7:19158000-19159400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
26	chr7:19158200-19158800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
27	chr7:19158200-19158800	Bivalent Enhancer	Placenta	Placenta
28	chr7:19158200-19159000	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
29	chr7:19158200-19159000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr7:19158200-19159000	Bivalent Enhancer	Brain Anterior Caudate	brain
31	chr7:19158200-19159200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr7:19158200-19159200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr7:19158200-19159800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
34	chr7:19158400-19158800	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr7:19158400-19158800	Bivalent Enhancer	Brain Angular Gyrus	brain
36	chr7:19158400-19158800	Bivalent Enhancer	Right Ventricle	heart
37	chr7:19158400-19159000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr7:19158400-19159000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
39	chr7:19158400-19159000	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr7:19158400-19159000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
41	chr7:19158400-19159000	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr7:19158400-19159000	Flanking Bivalent TSS/Enh	NH-A	brain
43	chr7:19158400-19159200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
44	chr7:19158400-19159200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
45	chr7:19158400-19160000	Bivalent Enhancer	Fetal Stomach	stomach
46	chr7:19158400-19161600	Weak transcription	Osteobl	bone
47	chr7:19158600-19158800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
48	chr7:19158600-19158800	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr7:19158600-19158800	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr7:19158600-19158800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links